Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eszopiclone for insomnia related to GAD
NCT00235508Phase 4Completed
- Sponsor
- Sumitomo Pharma America
- Start
- Jun 2005
- Primary completion
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of eszopiclone in Insomnia, sponsored by Sumitomo Pharma America. Started Jun 2005; status: completed.
02
Drugs
eszopiclone
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT00235508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00235508.